What is the best management approach for a patient with uncontrolled diabetes mellitus, impaired renal function, possible dehydration, electrolyte imbalances, a suspected infection, and elevated hemoglobin and hematocrit levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hyperglycemic Emergency with Suspected Infection and Renal Impairment

This patient requires immediate treatment for a hyperglycemic emergency (likely hyperosmolar hyperglycemic state given glucose 274 mg/dL, elevated osmolality 289, and leukocytosis 23.7) with aggressive fluid resuscitation, insulin therapy once hypokalemia is excluded, and urgent evaluation for the precipitating infection. 1

Immediate Recognition and Severity Assessment

This patient presents with multiple concerning features requiring urgent intervention:

  • Hyperglycemia (274 mg/dL) with elevated WBC (23.7) and neutrophilia (85.6%) strongly suggests infection as the precipitating cause 1, 2
  • Impaired renal function (eGFR 58.87, BUN 38, BUN/Cr ratio 42) indicates volume depletion and pre-renal azotemia 1
  • Elevated hematocrit (45.7) and hemoglobin (15.1) confirm significant dehydration through hemoconcentration 1
  • Calculated osmolality of 289 approaches the threshold for hyperosmolar state 3, 1

The combination of marked leukocytosis with left shift, hyperglycemia, and dehydration mandates immediate evaluation for diabetic ketoacidosis versus hyperosmolar hyperglycemic state. Check serum ketones, arterial or venous pH, and anion gap immediately to differentiate between these conditions, as one-third of hyperglycemic emergencies present with hybrid DKA-HHS features. 1, 4

Step 1: Immediate Fluid Resuscitation (First Hour)

Begin isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour during the first hour to restore circulatory volume and tissue perfusion. 3, 1, 2 For an average 70 kg patient, this translates to 1-1.5 liters in the first hour. 3

The elevated BUN/creatinine ratio of 42 (normal <20) confirms significant volume depletion requiring aggressive rehydration. 1 The goal is to correct estimated fluid deficits within 24 hours, which typically range from 6-9 liters in hyperglycemic emergencies. 3

Critical monitoring point: The induced change in serum osmolality should not exceed 3-8 mOsm/kg/hour to prevent cerebral edema. 1 This is particularly important given the patient's already elevated osmolality.

Step 2: Potassium Assessment Before Insulin

Do not start insulin until serum potassium is confirmed to be adequate (>3.3 mEq/L). 3, 1 This patient's current potassium is 4.0 mEq/L, which is acceptable to proceed with insulin therapy.

However, begin potassium replacement when serum levels fall below 5.2-5.5 mEq/L (provided adequate urine output is present), as insulin therapy drives potassium intracellularly and can cause life-threatening hypokalemia. 1 Add 20-30 mEq/L potassium to IV fluids (2/3 KCl and 1/3 KPO4). 3

Monitor serum potassium levels every 2-4 hours during acute management. 1

Step 3: Insulin Therapy Initiation

Once hypokalemia is excluded, administer intravenous insulin bolus of 0.1 units/kg body weight, followed by continuous infusion at 0.1 units/kg/hour. 4

Target blood glucose of 140-180 mg/dL (7.8-10.0 mmol/L) for most hospitalized patients once stabilized. 1, 2 This range balances glycemic control while avoiding hypoglycemia during acute illness.

When blood glucose reaches 250-300 mg/dL, switch to dextrose-containing fluids (D5W in 0.45% NaCl) while continuing insulin infusion to prevent hypoglycemia and allow continued correction of metabolic abnormalities. 3

Step 4: Infection Management

Obtain blood cultures, urine culture, chest X-ray, and other cultures as indicated before starting antibiotics. 3, 2 The marked leukocytosis (23.7) with 85.6% neutrophils strongly suggests bacterial infection as the precipitating cause. 1, 2

Infection is the most common precipitating factor in hyperglycemic emergencies, and immediate empiric antibiotic therapy should be initiated once cultures are obtained if infection is suspected. 1, 2

Step 5: Ongoing Monitoring Requirements

Continuous monitoring by experienced physicians is essential with the following parameters: 1

  • Blood glucose every 1-2 hours initially 1, 2
  • Electrolytes, BUN, creatinine, osmolality every 2-4 hours 1, 4
  • Vital signs and mental status continuously 1
  • Venous pH every 2-4 hours if DKA component present 1

Step 6: Fluid Strategy After First Hour

After the initial hour of isotonic saline, switch to 0.45% NaCl at 4-14 mL/kg/hour if corrected serum sodium is normal or elevated (corrected sodium = measured sodium + 1.6 × [(glucose - 100)/100]). 3 This patient's sodium of 135 is low-normal, but must be corrected for hyperglycemia.

If corrected serum sodium is low, continue 0.9% NaCl at similar rates. 3

Special Considerations for Renal Impairment

This patient's eGFR of 58.87 mL/min/1.73 m² (CKD stage 3a) requires specific considerations:

  • HbA1c of 6.2% may be reasonably accurate at this eGFR level (>30 mL/min/1.73 m²), though interpretation should consider potential limitations. 3
  • Avoid metformin in this acute setting given renal impairment and risk of lactic acidosis. 5
  • Insulin clearance is impaired with reduced kidney function, increasing hypoglycemia risk during recovery. 3
  • Monitor for electrolyte abnormalities closely, as CKD patients are prone to hyperkalemia, metabolic acidosis, and sodium disturbances. 6, 7

Transition to Subcutaneous Insulin

Transition from intravenous to subcutaneous insulin 2-4 hours before stopping intravenous insulin to prevent rebound hyperglycemia. 4 Use a basal-bolus insulin regimen (basal insulin plus prandial rapid-acting insulin) once the patient has adequate oral intake. 1, 2

Calculate total daily insulin dose at 0.5-0.8 units/kg/day based on patient's weight, divided into basal insulin (50%) and prandial insulin (50%). 2

Critical Pitfalls to Avoid

  • Never use sliding-scale insulin as monotherapy during acute illness—this approach is ineffective and leads to wide glucose fluctuations. 2
  • Do not correct hyperglycemia too rapidly—aim for glucose reduction of 50-70 mg/dL per hour to avoid osmotic complications. 3, 1
  • Never discontinue insulin completely even when infection resolves, as this can precipitate recurrent hyperglycemic crisis. 4, 2
  • Avoid oral hypoglycemic agents during acute illness, especially with impaired oral intake. 2

Discharge Planning and Prevention

Develop a structured discharge plan that addresses: 1, 2

  • The underlying precipitating cause (infection in this case)
  • Diabetes self-management education focusing on medication adherence and sick-day management 2
  • Never discontinue insulin during intercurrent illness—this is a critical teaching point to prevent future hyperglycemic emergencies 1, 4
  • Ensure adequate supervision, particularly important given the patient's age-related considerations 1
  • Close follow-up within 1-2 weeks to reassess glycemic control and renal function 2

References

Guideline

Management of Hyperglycemic Hyperosmolar Syndrome (HHS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hyperglycemia with UTI in Uncontrolled Diabetes Mellitus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hyperglycemia and Ataxia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diabetes mellitus and renal failure: Prevention and management.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 2015

Research

Acid-base and electrolyte disorders in patients with diabetes mellitus.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.